Understanding how some people resist Alzheimer's disease progression

Genetic resiliency to disease progression in Alzheimer's disease

NIH-funded research Baylor College of Medicine · NIH-11001930

This study is looking at why some people with Alzheimer's can still think clearly even though they have the disease, by examining special mice and how social interactions might help keep their brains healthy.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-11001930 on NIH RePORTER

What this research studies

This research investigates the mechanisms behind why some individuals with Alzheimer's disease (AD) show resilience against cognitive decline despite having the disease's neuropathology. By studying transgenic mice that mimic human AD, researchers aim to identify biological markers associated with resilience, particularly focusing on the expression of ΔFosB in the brain. The study also explores the role of social interaction in reducing dementia risk, which could provide insights into potential therapeutic strategies for patients. Through this approach, the research seeks to uncover factors that help maintain cognitive function in the face of Alzheimer's pathology.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease who may exhibit varying degrees of cognitive function despite their diagnosis.

Not a fit: Patients with advanced Alzheimer's disease who are already experiencing significant cognitive decline may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or slowing cognitive decline in Alzheimer's patients.

How similar studies have performed: Previous research has shown promise in understanding resilience in Alzheimer's through similar animal models, indicating potential for breakthroughs in human applications.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.